Obesity and Cancer Part: 1 of the diabetes and cancer mini-review series

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 10, 2009, Pages 563-566

  Percik, R ^a   Stumvoll, M ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adipocytokines; Cancer; Estrogens; Insulin; Leptin; Obesity

Indexed keywords

CARCINOGEN; INSULIN; LEPTIN; SEX HORMONE; SOMATOMEDIN C;

ADIPOSE TISSUE; BODY COMPOSITION; BREAST CARCINOGENESIS; CALORIC INTAKE; CALORIC RESTRICTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CAUSAL ATTRIBUTION; COLON CARCINOGENESIS; DIABETES MELLITUS; DIETARY INTAKE; ENDOMETRIUM CANCER; EPIDEMIOLOGICAL DATA; ESOPHAGUS CARCINOMA; FOOD INTAKE; GALLBLADDER CARCINOMA; GALLSTONE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERGLYCEMIA; INFLAMMATION; KIDNEY CARCINOMA; LIVER CARCINOGENESIS; OBESITY; PANCREAS CARCINOMA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; COMORBIDITY; METABOLISM; NEOPLASM; REVIEW;

ADIPOSITY; COMORBIDITY; ENERGY INTAKE; HUMANS; INFLAMMATION; INSULIN; LEPTIN; NEOPLASMS; OBESITY; RISK FACTORS;

EID: 70450228533     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1241870     Document Type: Short Survey

References (35)

1. Ogdan C. Advanced Data from Vital Health Statistics CDC. 2004
2. Olshansky SJ, Passaro DJ, Hershaw RC et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352:1138-1145 (Pubitemid 40365358)
3. Vainio H, Bianchtni F. Weight control and physical activity. International Agency for Cancer handbook of cancer prevention, Lyon: IARC 2002;6
4. Renehan AC, Tyson M, Egger M et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578 (Pubitemid 351232031)
5. Mokdad AH, Marks JS, Stroup DF et al. Actual causes of death in the United States, 2000. JAMA 2004; 291: 1238-1245
6. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591 (Pubitemid 39025053)
7. Hursting SD, Lashinger LM, Wheatley KW et al. Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract Res Clin Endocrinol Metab 2008; 22: 659-669
8. Jayachandran J, Banez LL, Aronson WJ et al. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer 2009
9. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3: 565-574
10. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-1638
11. Calanis DJ, Kolonel LN, Lee J et al. Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States. Cancer Causes Control 1998; 9: 217-224 (Pubitemid 28160977)
12. Trentham-Dietz A, Newcomb PA, Egan KM et al. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 2000; 11:533-542 (Pubitemid 30342842)
13. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002; 11: 1531-1543 (Pubitemid 36020003)
14. Hu J, Mao Y, White K. Overweight and obesity in adults and risk of renal cell carcinoma in Canada. Soz Praventivmed 2003; 48: 178-185 (Pubitemid 36889490)
15. Bergstrom A, Pisani P, Tenet V et al Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91: 421-430 (Pubitemid 32049639)
16. Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 2003; 3: 676-684
17. Lagergren J. Increased incidence of adenocarcinoma of the esophagus and cardia. Reflux and obesity are strong and independent risk factors according to the SECC study. Lakartidningen 2000; 97: 1950-1953
18. Nilsson M, Johnsen R, Ye W et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003; 290: 66-72 (Pubitemid 37432867)
19. Gapstur SM, Cann PH, Lowe W et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000; 283: 2552-2558 (Pubitemid 30324198)
20. Silverman DT, Swansan CA, Cridley C et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1998; 90: 1710-1719
21. Wolk A, Grldley G, Svensson M et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001; 12: 13-21 (Pubitemid 32125897)
22. Strom BL, Soloway RD, Rios-Dalenz JL et al. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 1995; 76: 1747-1756
23. Pan SY, DesMeules M. Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence. Methods Mol Biol 2009; 472: 191-215
24. Key TJ, Allen NE, Spencer EA et al. The effect of diet on risk of cancer. Lancet 2002; 360: 861-868
25. Thompson HJ. Ovesity as a cancer risk factor: potential mechanisms. Nutrition and Cancer Previntion, Taylor & Francis, Boca Raton, FL, pp 2006; 565-657
26. Yakar S, Leroith D, Brodt P. The role of the growth hormone/insulinlike growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev 2005; 16: 407-420 (Pubitemid 41022011)
27. Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006; 441: 424-430 (Pubitemid 44050136)
28. Lukanova A, Zeleniuch-Jacquatte A, Lundin E et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP-I, -2 and -3 and risk of endometrial cancer. Int J Cancer 2004; 108: 262-268 (Pubitemid 37541781)
29. Abe R, Yamagishi S. AGE-RAGE system and carcinogenesis. Curr Pharm Des 2008; 14: 940-945
30. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355 (Pubitemid 40277057)
31. Feagins LA, Souza RF, Spechler SJ. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol 2009; 6: 297-305
32. Stattin P, Lukanova A, Biessy C et al. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004; 109: 149-152
33. Fentan JI, Hord NG, LavigneJA et al. Leptin, insulin-like growth factor1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Ape+/+ colonic epithelial cell lines. Cancer Epidemiol Biomarkers Prev 2005; 14: 1646-1652
34. Rajala MW, Scherer PE. Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144: 3765-3773
35. Gonzalez RR, Cherfils S, Escobar M et al. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 2006; 281: 26320-26328 (Pubitemid 44401840)